Cabaletta Bio, Inc.

NASDAQ:CABA

Biotechnology

Healthcare
$1.02 +1.23%

+$0.04 today

Market cap
$220.03M
Beta
3.23
P/E (TTM)
-1.8
EPS (TTM)
-$1.57
52W Low $1.26High $4.23

Volume 5.46M

Average 3.33M

Balance Sheet

Inspect the capital base behind the business.

Assets

$165.08M

FY 2025 · Annual

-10.8% YoY

Liabilities

$53.03M

FY 2025 · Annual

+62.1% YoY

Equity

$112.05M

FY 2025 · Annual

-26.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents122.22M81.61M193.24M163.96M82.98M
Short-term Investments024.94M48.01M050.62M
Net Receivables00000
Inventory00000
Other Current Assets1.97M2.29M02.71M5.27M
Total Current Assets124.54M108.83M244.49M166.68M138.87M
Property, Plant & Equipment (Net)1.44M7.57M7.45M16.08M21.05M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets357K565K1.71M6.23M5.16M
Total Non-current Assets1.8M8.13M9.16M22.31M26.21M
Total Assets126.34M116.97M253.65M185.05M165.08M
Account Payables2.33M2.46M4.55M4.92M6.64M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities3.07M1.33M40K8.36M9.8M
Total Current Liabilities8.38M9.49M15.99M27.09M50.15M
Long-term Debt00002.88M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities02.96M1.46M5.63M2.88M
Total Liabilities8.38M12.45M17.45M32.71M53.03M
Common Stock0001K1K
Retained Earnings(112.59M)(165.56M)(233.24M)(349.1M)(516.96M)
Accumulated OCI0(47K)39K025K
Other Stockholders Equity00000
Minority Interest00000
Total Equity117.96M104.52M236.2M152.34M112.05M
Total Debt05.14M5.02M15.6M27.1M
Net Debt(122.22M)(76.47M)(188.22M)(148.36M)(55.88M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$116.6M
Other Current$5.7M
Total Current Assets$122.3M
PP&E (Net)$20.6M
Other Non-current$5.3M
Total Non-current Assets$25.8M
Total Assets$148.1M

Analysis

Selected assets total $148.1M for Latest. The largest visible component is Cash & Equivalents at $116.6M, about 78.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 12, 2026
8-KCurrent reportNov 9, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
8-KCurrent reportNov 5, 2026

How much cash does CABA have?

Cabaletta Bio, Inc. (CABA) reported $82.98M in cash and equivalents in fiscal 2025.

How much debt does CABA carry?

Cabaletta Bio, Inc. (CABA) reported $27.10M of total debt, with net debt of -$55.88M.